Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterizing caspase-1 involvement during esophageal disease progression.
Barber G, Anand A, Katarzyna Oficjalska, Phelan JJ, Heeran AB, Flis E, Clarke NE, Watson JA, Strangmann J, Flood B, O'Neill H, O'Toole D, MacCarthy F, Ravi N, Reynolds JV, Kay EW, Quante M, O'Sullivan J, Creagh EM. Barber G, et al. Among authors: watson ja. Cancer Immunol Immunother. 2020 Dec;69(12):2635-2649. doi: 10.1007/s00262-020-02650-4. Epub 2020 Jul 1. Cancer Immunol Immunother. 2020. PMID: 32613271 Free PMC article.
HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.
Dunne MR, Michielsen AJ, O'Sullivan KE, Cathcart MC, Feighery R, Doyle B, Watson JA, O'Farrell NJ, Ravi N, Kay E, Reynolds JV, Ryan EJ, O'Sullivan J. Dunne MR, et al. Among authors: watson ja. Cancer Immunol Immunother. 2017 Jul;66(7):841-850. doi: 10.1007/s00262-017-1983-1. Epub 2017 Mar 18. Cancer Immunol Immunother. 2017. PMID: 28315927 Free PMC article.
Recurrence of urothelial carcinoma of the bladder: a role for insulin-like growth factor-II loss of imprinting and cytoplasmic E-cadherin immunolocalization.
Gallagher EM, O'Shea DM, Fitzpatrick P, Harrison M, Gilmartin B, Watson JA, Clarke T, Leonard MO, McGoldrick A, Meehan M, Watson C, Furlong F, O'Kelly P, Fitzpatrick JM, Dervan PA, O'Grady A, Kay EW, McCann A. Gallagher EM, et al. Among authors: watson c, watson ja. Clin Cancer Res. 2008 Nov 1;14(21):6829-38. doi: 10.1158/1078-0432.CCR-08-0577. Clin Cancer Res. 2008. PMID: 18980977 Free article.
Generation of an epigenetic signature by chronic hypoxia in prostate cells.
Watson JA, Watson CJ, McCrohan AM, Woodfine K, Tosetto M, McDaid J, Gallagher E, Betts D, Baugh J, O'Sullivan J, Murrell A, Watson RW, McCann A. Watson JA, et al. Among authors: watson rw, watson cj. Hum Mol Genet. 2009 Oct 1;18(19):3594-604. doi: 10.1093/hmg/ddp307. Epub 2009 Jul 7. Hum Mol Genet. 2009. PMID: 19584087
MAD2 downregulation in hypoxia is independent of promoter hypermethylation.
Prencipe M, McGoldrick A, Perry AS, O'Grady A, Phelan S, McGrogan B, Fitzpatrick P, Watson JA, Furlong F, Brennan DJ, Lawler M, Kay E, McCann A. Prencipe M, et al. Among authors: watson ja. Cell Cycle. 2010 Jul 15;9(14):2856-65. Epub 2010 Jul 12. Cell Cycle. 2010. PMID: 20676051
248 results